Sorry, available market cap data for ProPhase Labs (PRPH) starts on October 1, 1996. ProPhase Labs (PRPH) has a market capitalization of $46.6M, based on 19.08M shares at a price of $2.44 (up 2.5% yesterday).

Americas Car-Mart (CRMT) had the highest return in 1993 by a US stock, returning 1,242.7%.

Lisata Therapeutics (LSTA) had the highest return in 1994 by a US stock, returning 4,285,614.3%.

Lisata Therapeutics (LSTA) had the highest return between 1994 and 1997 by a US stock, returning 1,178,471.4%.

QQQ had its best month this year in May 2024, returning 6.5%.

Portage Biotech (PRTG) had the highest return between 1995 and 1997 by a US stock, returning 111,900%.

Madrigal Pharmaceuticals (MDGL) had the highest return between November 1, 2022 and December 31, 2022 by a mid-cap US stock or mid-cap US stock, returning 301.6%.

INVO Bioscience (INVO) returned -85% last year.

INVO Bioscience (INVO) returned -58.4% in 2019.

INVO Bioscience (INVO) returned 169.2% in 2018.

INVO Bioscience (INVO) returned -55.7% in 2017.

INVO Bioscience (INVO) returned 914.5% in 2016.

INVO Bioscience (INVO) returned -86.5% in 2015.

INVO Bioscience (INVO) returned 381.5% in 2014.

INVO Bioscience (INVO) returned 260% in 2013.